Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science. 1995;270(5234):286–90. https://doi.org/10.1126/science.270.5234.286.

Article  CAS  PubMed  Google Scholar 

Liu D, Ahmet A, Ward L, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 2013;9(1):30. https://doi.org/10.1186/1710-1492-9-30.

Article  PubMed  PubMed Central  Google Scholar 

Drucker AM, Eyerich K, de Bruin-Weller MS, et al. Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement. Br J Dermatol. 2018;178(3):768–75. https://doi.org/10.1111/bjd.15928.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Buonavoglia A, Leone P, Dammacco R, et al. Pemphigus and mucous membrane pemphigoid: an update from diagnosis to therapy. Autoimmun Rev. 2019;18(4):349–58. https://doi.org/10.1016/j.autrev.2019.02.005.

Article  PubMed  Google Scholar 

Overman RA, Yeh JY, Deal CL. Prevalence of oral glucocorticoid usage in the United States: a general population perspective. Arthritis Care Res (Hoboken). 2013;65(2):294–8. https://doi.org/10.1002/acr.21796.

Article  PubMed  Google Scholar 

Marcus MW, Müskens RP, Ramdas WD, et al. Corticosteroids and open-angle glaucoma in the elderly: a population-based cohort study. Drugs Aging. 2012;29(12):963–70. https://doi.org/10.1007/s40266-012-0029-9.

Article  CAS  PubMed  Google Scholar 

Curtis JR, Westfall AO, Allison J, et al. Population-based assessment of adverse events associated with long-term glucocorticoid use. Arthritis Rheum. 2006;55(3):420–6. https://doi.org/10.1002/art.21984.

Article  PubMed  Google Scholar 

Borradori L, Van Beek N, Feliciani C, et al. Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2022;36(10):1689–704. https://doi.org/10.1111/jdv.18220.

Article  CAS  PubMed  Google Scholar 

Chams-Davatchi C, Esmaili N, Daneshpazhooh M, et al. Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris. J Am Acad Dermatol. 2007;57(4):622–8. https://doi.org/10.1016/j.jaad.2007.05.024.

Article  PubMed  Google Scholar 

Schmidt E, Sticherling M, Sárdy M, et al. S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid: 2019 update. J Dtsch Dermatol Ges. 2020;18(5):516–26. https://doi.org/10.1111/ddg.14097.

Article  PubMed  Google Scholar 

Yu SH, Drucker AM, Lebwohl M, Silverberg JI. A systematic review of the safety and efficacy of systemic corticosteroids in atopic dermatitis. J Am Acad Dermatol. 2018;78(4):733-740.e11. https://doi.org/10.1016/j.jaad.2017.09.074.

Article  CAS  PubMed  Google Scholar 

Ramamoorthy S, Cidlowski JA. Corticosteroids: mechanisms of action in health and disease. Rheum Dis Clin North Am. 2016;42(1):15–vii. https://doi.org/10.1016/j.rdc.2015.08.002.

Article  PubMed  PubMed Central  Google Scholar 

Czock D, Keller F, Rasche FM, Häussler U. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet. 2005;44(1):61–98. https://doi.org/10.2165/00003088-200544010-00003.

Article  CAS  PubMed  Google Scholar 

Kane SP. Corticosteroid Conversion Calculator. ClinCalc. Updated 24 October 2015. Available at: https://clincalc.com/Corticosteroids. Accessed 23 Feb 2024.

Gom I, Fukushima H, Shiraki M, et al. Relationship between serum albumin level and aging in community-dwelling self-supported elderly population. J Nutr Sci Vitaminol (Tokyo). 2007;53(1):37–42. https://doi.org/10.3177/jnsv.53.37.

Article  PubMed  Google Scholar 

Piper JM, Ray WA, Daugherty JR, Griffin MR. Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Intern Med. 1991;114(9):735–40. https://doi.org/10.7326/0003-4819-114-9-735.

Article  CAS  PubMed  Google Scholar 

Tseng CL, Chen YT, Huang CJ, et al. Short-term use of glucocorticoids and risk of peptic ulcer bleeding: a nationwide population-based case-crossover study. Aliment Pharmacol Ther. 2015;42(5):599–606. https://doi.org/10.1111/apt.13298.

Article  CAS  PubMed  Google Scholar 

Tornatore KM, Logue G, Venuto RC, Davis PJ. Pharmacokinetics of methylprednisolone in elderly and young healthy males. J Am Geriatr Soc. 1994;42(10):1118–22. https://doi.org/10.1111/j.1532-5415.1994.tb06219.x.

Article  CAS  PubMed  Google Scholar 

Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. Updated 2023. Available at: https://ginasthma.org/2023-gina-main-report/. Accessed 23 Aug 2023.

Bajaj JS, Wong F, Kamath PS, Lai JC, O’Leary JG. Acute-on-chronic liver failure. Am J Gastroenterol. 2022;117(6):831–4. https://doi.org/10.14309/ajg.0000000000001748.

Article  PubMed  Google Scholar 

Joly P, Roujeau JC, Benichou J, et al. Bullous Diseases French Study Group. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med. 2002;346(5):321–7. https://doi.org/10.1056/NEJMoa011592.

Article  CAS  PubMed  Google Scholar 

Da Silva JA, Jacobs JW, Kirwan JR, et al. Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann Rheum Dis. 2006;65(3):285–93.

Article  PubMed  Google Scholar 

Huscher D, Thiele K, Gromnica-Ihle E, et al. Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis. 2009;68(7):1119–24. https://doi.org/10.1136/ard.2008.092163.

Article  CAS  PubMed  Google Scholar 

Saag KG, Koehnke R, Caldwell JR, et al. Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med. 1994;96(2):115–23. https://doi.org/10.1016/0002-9343(94)90131-7.

Article  CAS  PubMed  Google Scholar 

Ito SM, Yamanashi Y, Takada T, Suzuki H. Clinical importance of drug–drug interaction between warfarin and prednisolone and its potential mechanism in relation to the Niemann-Pick C1-like 1-mediated pathway. Circ J. 2019;83(2):471–80. https://doi.org/10.1253/circj.CJ-18-0807.

Article  CAS  PubMed  Google Scholar 

Smith SF. Lipocortin 1. glucocorticoids caught in the act? Thorax. 1996;51(10):1057–9. https://doi.org/10.1136/thx.51.10.1057.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Coutinho AE, Chapman KE. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol. 2011;335(1):2–13. https://doi.org/10.1016/j.mce.2010.04.005.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rice JB, White AG, Scarpati LM, Wan G, Nelson WW. Long-term systemic corticosteroid exposure: a systematic literature review. Clin Ther. 2017;39(11):2216–29. https://doi.org/10.1016/j.clinthera.2017.09.011.

Article  CAS  PubMed  Google Scholar 

Weyand CM, Goronzy JJ. Aging of the immune system. Mechanisms and therapeutic targets. Ann Am Thorac Soc. 2016;13(Suppl 5):S422–8. https://doi.org/10.1513/AnnalsATS.201602-095AW.

Article  PubMed  PubMed Central  Google Scholar 

Fardet L, Petersen I, Nazareth I. Common infections in patients prescribed systemic glucocorticoids in primary care: a population-based cohort study. PLoS Med. 2016;13(5): e1002024. https://doi.org/10.1371/journal.pmed.1002024.

Article  CAS  PubMed  PubMed Central